实用药物与临床
實用藥物與臨床
실용약물여림상
PRACTICAL PHARMACY AND CLINICAL REMEDIES
2015年
8期
939-941
,共3页
潘先芳%王庆松%肖莉%彭芳
潘先芳%王慶鬆%肖莉%彭芳
반선방%왕경송%초리%팽방
缺血性脑卒中%抗焦虑治疗%躯体化症状
缺血性腦卒中%抗焦慮治療%軀體化癥狀
결혈성뇌졸중%항초필치료%구체화증상
Ischemic stroke%Anti-depression treatment%Somatizated symptoms
目的:探讨缺血性脑卒中后急性期的躯体化症状临床特征以及抗焦虑治疗的临床疗效。方法分析主诉身体不适的238例急性缺血性脑卒中患者的临床特征。将238例患者随机分成2组,分别为治疗组122例,对照组116例,对照组给予常规神经系统药物及对症治疗,治疗组在对照组的基础上给予黛力新治疗,在治疗前以及治疗后第1、2、4周采用症状自评量表(SCL-90)、汉密尔顿抑郁量表(HAMD)和汉密尔顿焦虑量表(HAMA)进行评分。结果治疗组在1、2、4周时,SCL-90评分、HAMD 和 HAMA 均较治疗前明显降低(P <0.05),并且显著低于对照组治疗后(P<0.05)。结论缺血性脑卒中后急性期的躯体化临床症状表现多种多样,涉及全身各个系统,抗焦虑药物治疗对以躯体化症状为主诉的缺血性脑卒中后急性期患者疗效肯定。
目的:探討缺血性腦卒中後急性期的軀體化癥狀臨床特徵以及抗焦慮治療的臨床療效。方法分析主訴身體不適的238例急性缺血性腦卒中患者的臨床特徵。將238例患者隨機分成2組,分彆為治療組122例,對照組116例,對照組給予常規神經繫統藥物及對癥治療,治療組在對照組的基礎上給予黛力新治療,在治療前以及治療後第1、2、4週採用癥狀自評量錶(SCL-90)、漢密爾頓抑鬱量錶(HAMD)和漢密爾頓焦慮量錶(HAMA)進行評分。結果治療組在1、2、4週時,SCL-90評分、HAMD 和 HAMA 均較治療前明顯降低(P <0.05),併且顯著低于對照組治療後(P<0.05)。結論缺血性腦卒中後急性期的軀體化臨床癥狀錶現多種多樣,涉及全身各箇繫統,抗焦慮藥物治療對以軀體化癥狀為主訴的缺血性腦卒中後急性期患者療效肯定。
목적:탐토결혈성뇌졸중후급성기적구체화증상림상특정이급항초필치료적림상료효。방법분석주소신체불괄적238례급성결혈성뇌졸중환자적림상특정。장238례환자수궤분성2조,분별위치료조122례,대조조116례,대조조급여상규신경계통약물급대증치료,치료조재대조조적기출상급여대력신치료,재치료전이급치료후제1、2、4주채용증상자평량표(SCL-90)、한밀이돈억욱량표(HAMD)화한밀이돈초필량표(HAMA)진행평분。결과치료조재1、2、4주시,SCL-90평분、HAMD 화 HAMA 균교치료전명현강저(P <0.05),병차현저저우대조조치료후(P<0.05)。결론결혈성뇌졸중후급성기적구체화림상증상표현다충다양,섭급전신각개계통,항초필약물치료대이구체화증상위주소적결혈성뇌졸중후급성기환자료효긍정。
Objective To study the clinical features of somatizated symptoms in patients of ischemic stroke in acute phase and the clinical efficacy of the anti-depression treatment. Methods A total of 238 patients with somatizat-ed symptoms of ischemic stroke in acute phase were analyzed for the clinical features and were randomly divided into treatment group(n=122) and control group(n=116). The control group received conventional nervous system drugs, symptomatic and supportive treatment, treatment group received Deanxit on the basis of control group. The efficacy were assessed by SCL-90, HAMD and HAMA before treatment and at the end of 1st, 2nd, 4th day after treat-ment. Results The scores of SCL-90,HAMD and HAMA of patients in treatment group significantly decreased at the 1st,2nd,4th week(P<0. 05). The scores of treatment group were lower than those of control group,the differences were statistically significant(P<0. 05). Conclusion The clinical features of somatizated symptoms in patients of is-chemic stroke are diverse and involved in multi system. Anti-depression treatment is effective in the treatment of soma-tizated symptoms of ischemic stroke in acute phase.